Markowitz, Sanford D. |
Case Western Reserve University
United States |
Validation of Biomarkers for predicting Barrett's esophagus that will or will not: i) progress towards cancer, or ii) recur after ablation |
5U01CA271867-02 |
|
Matthew Young, Ph.D. |
Laack, Nadia N |
Mayo Clinic Rochester
United States |
Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy |
5U01CA246568-05 |
|
Marge Good, R.N., M.P.H., O.C.N. |
Sedrak, Mina S |
University Of California Los Angeles
United States |
Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors |
5R21CA277660-03 |
|
Goli Samimi, Ph.D., M.P.H. |
Permuth, Jennifer B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology |
5R37CA229810-05 |
|
Matthew Young, Ph.D. |
Goggins, Michael G. |
Johns Hopkins University
United States |
Using markers to improve pancreatic cancer screening and surveillance: a multi-center study |
5U01CA210170-07 |
|
Matthew Young, Ph.D. |
Goggins, Michael G. |
Johns Hopkins University
United States |
Using Markers to Improve Pancreatic Cancer Screening |
5R01CA176828-09 |
|
Matthew Young, Ph.D. |
Kong, Mei |
University Of California-Irvine
United States |
Using dietary glutamine supplementation for melanoma prevention and targeted therapy |
5R01CA244360-03 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Gabriela Riscuta, M.D., C.N.S. |
Torres, Keila Enitt |
University Of Tx Md Anderson Can Ctr
United States |
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
1R01CA285980-01 |
|
Richard Mazurchuk, Ph.D. |
Shu, Xiao-Ou |
Vanderbilt University Medical Center
United States |
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer |
5R01CA227133-05 |
|
Matthew Young, Ph.D. |
Lokshin, Anna E |
University Of Pittsburgh At Pittsburgh
United States |
Urine and serum biomarkers for early diagnosis and risk assessment of pancreatic cancer |
5R01CA254036-04 |
|
Matthew Young, Ph.D. |